Harvard Bioscience (HBIO) Tops Q4 EPS by 2c, Guides for Q1 and FY08
More News related to HBIO
- Harvard Bioscience (HBIO) Posts Q3 EPS of $0.04, Down Y/Y
- HBIO Reports Third Quarter 2009 Revenue Growth of 5% Over Third Quarter 2008
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Harvard Bioscience, Inc. Schedules Third Quarter 2009 Conference Call for November 4, 2009
- Harvard Bioscience (HBIO) Appoints McNaughton New CFO
More News related to Earnings
- Jo-Ann Stores (JAS) Falls As Investors Yawn at In-Line Results and Guidance
- Dynamex (DDMX) Posts Q1 EPS of $0.31, Tops by 5c
- Dynamex (DDMX) Reports Q1 EPS of $0.31, Beats by 5c
- Aeropostale (ARO) Delivers In 3Q, But Important 4Q Guidance Not Rosy Enough
- SeaChange (SEAC) Reports Solid Q3 Results; Guides Q4, FY11
Harvard Bioscience, Inc. (Nasdaq: HBIO) reports Q4 adjusted non-GAAP EPS of $0.10, 2 cents better than estimates. Revenues were $24.5 million vs. $23.00 million consensus.
Sees FY08 revenues between $94.0 million and $96.0 million and adjusted non-GAAP earnings per diluted share from continuing operations between $0.36 and $0.38 for 2008. (Consensus is $92.00 million and $0.35, respectively)
Sees approx. $23.0 million in revenues for Q1 and adjusted non-GAAP earnings per diluted share from continuing operations of approximately $0.08. (Consensus is $22.00 million and $0.08, respectively)
Related Categories
EarningsGuidance
Stocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
